Monica Thomas - May 22, 2023 Form 4 Insider Report for G1 Therapeutics, Inc. (GTHX)

Signature
/s /Sandi James, attorney-in-fact
Stock symbol
GTHX
Transactions as of
May 22, 2023
Transactions value $
$0
Form type
4
Date filed
5/24/2023, 04:41 PM
Next filing
Jan 8, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GTHX Common Stock Award $0 +50K +28409.09% $0.00 50.2K May 22, 2023 Direct F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GTHX Stock Options (Right to buy) Award $0 +150K $0.00 150K May 22, 2023 Common Stock 150K $2.88 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a restricted stock unit ("RSU") award that vests 25% on May 22, 2024 and 25% annually thereafter, subject to the Reporting Person's continued service through each applicable vesting date.
F2 Each RSU represents a contingent right to receive one share of Issuer common stock.
F3 Represents (i) 176 shares of common stock; and (ii) 50,000 RSUs from award granted on May, 22 2023.
F4 The shares underlying this option vest as to 25% of the shares on May 22, 2024, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each applicable vesting date.